Pdt Partners, LLC Avrobio, Inc. Transaction History

Pdt Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.29 - $4.04 $77,013 - $241,188	-59,700 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$3.45 - $6.05 $45,943 - $80,567	-13,317 Reduced 18.24%	59,700 $230,000
Q3 2021 Nov 15, 2021	BUY	$5.53 - $9.28 $91,880 - $154,187	16,615 Added 29.46%	73,017 $407,000
Q2 2021 Aug 16, 2021	BUY	$7.84 - $12.6 $442,191 - $710,665	56,402 New	56,402 $501,000

28.1M

100

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.